BIM-23056

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBIM-23056
Drug Alias NameBIM-23056
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSomatostatin receptor 5 antagonists
TargetsSomatostatin receptor 5
Therapy Area/IndicationsStomach Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen SA
Active IndicationsN/A
Inactive IndicationsStomach Ulcer

Other Information

ATC CodeN/A
Related LinksN/A